Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

40
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
40
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

70
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
70
Pharmacovigilance01:19

Pharmacovigilance

1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

2.4K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.4K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

722
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
722

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability.

Expert review of clinical pharmacology·2024
Same author

Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review.

European journal of clinical pharmacology·2022
Same author

Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.

Pharmacoepidemiology and drug safety·2020
Same author

Association of Drug Burden Index with grip strength, timed up and go and Barthel index activities of daily living in older adults with intellectual disabilities: an observational cross-sectional study.

BMC geriatrics·2019
Same author

Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study.

British journal of clinical pharmacology·2017

Related Experiment Video

Updated: Nov 2, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.9K

Defensive pharmacy practice: a gap in our understanding.

Juliette O'Connell1

  • 1School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland. jaoconne@tcd.ie.

International Journal of Clinical Pharmacy
|June 14, 2021
PubMed
Summary
This summary is machine-generated.

Defensive practice, or engaging in behaviors to avoid lawsuits, is common in healthcare. Research is needed to understand its impact on pharmacy and improve patient care.

Keywords:
Defensive medicineDefensive practicePharmacy practiceSocial pharmacy

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.8K
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

10.8K

Related Experiment Videos

Last Updated: Nov 2, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.9K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.8K
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

10.8K

Area of Science:

  • Pharmacy Practice
  • Healthcare Management
  • Medical Ethics

Background:

  • Defensive practice is well-documented in medicine and nursing.
  • Little research exists on defensive practice in pharmacy.
  • Increased litigation and regulation may drive defensive behaviors in pharmacists.

Purpose of the Study:

  • To investigate the phenomenon of defensive practice in pharmacy.
  • To understand its potential impact on healthcare costs, quality of care, and pharmacist job satisfaction.
  • To identify the need for research to improve pharmacy practice and patient outcomes.

Main Methods:

  • This study highlights the need for research into defensive practice in pharmacy.
  • It identifies influences similar to those in other healthcare professions.
  • Further research is proposed to explore this phenomenon.

Main Results:

  • Defensive practice in pharmacy is under-researched.
  • Pharmacists may adopt defensive behaviors due to litigation risks.
  • This practice can negatively impact healthcare costs and quality.

Conclusions:

  • Research on defensive practice in pharmacy is crucial.
  • Understanding this behavior can inform policy changes and professional representation.
  • Ultimately, this can lead to improved quality of care for patients.